XML 49 R38.htm IDEA: XBRL DOCUMENT
v3.21.2

INVESTMENT IN EQUITY SECURITIES (Details) - USD ($) | Sep. 30, 2021 | Dec. 31, 2020
--- | --- | ---
Cost method investment | $ 2,584,278 | $ 1,100,000
Total investments | 3,811,531 | 1,100,000
Equity method investment | 1,227,253 | 0
Direct Dermatology, Inc. [Member] |  |
Cost method investment | $ 500,000 | $ 500,000
Economic interest | 0.00% | 0.00%
Precision Healing Inc. [Member] |  |
Cost method investment | $ 0 | $ 600,000
Equity method investment | $ 1,227,253 | $ 0
Economic interest | 29.00% | 0.00%
Pixalere Healthcare, Inc [Member] |  |
Cost method investment | $ 2,084,278 |
Economic interest | 0.00% |

X
- References No definition available. + Details
Name: | smti_CostMethodInvestmentsEconomicInterest
Namespace Prefix: | smti_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | smti_EquityMethodInvestmentsEconomicInterest
Namespace Prefix: | smti_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Fair value portion of investments accounted under the cost method. + References No definition available. + Details
Name: | us-gaap_CostMethodInvestmentsFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value portion of investments accounted under the equity method. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 25 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=117311354&loc=d3e32014-111567 + Details
Name: | us-gaap_EquityMethodInvestmentsFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_InvestmentsFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | srt_TitleOfIndividualAxis=smti_DirectDermatologyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=smti_PrecisionHealingIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=smti_PixalereHealthcareIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |